Psychiatry and Neurology, Neurology · Norfolk, VA
NPI
1639361033
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6161 Kempsville Cir, Suite 315
Norfolk, VA, 23502
Phone (757) 461-5400
Groups this clinician bills Medicare through
Medicare paid, 2024
$395K
64,045 services
Medicare patients, 2024
707
Average age 75
Drug cost, 2024
$2.2M
3,119 prescriptions
Company payments, 2025
$95K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carmen R Fuentes was code J0174 (injection, lecanemab-irmb, 1 mg), 42,485 times for 22 patients. In total Carmen R Fuentes billed 64,045 services in 47 codes, and Medicare paid $395K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0174 Injection, lecanemab-irmb, 1 mg | Office | 42,485 | 22 | $1.05 | $45K |
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 10,900 | 17 | $4.89 | $53K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 774 | 502 | $12.29 | $9,514 |
| 99214 Office E&M - Established | Office | 410 | 316 | $87.29 | $36K |
| 99215 Office E&M - Established | Office | 404 | 273 | $128.69 | $52K |
| 99213 Office E&M - Established | Office | 138 | 119 | $58.27 | $8,042 |
| 96413 Chemotherapy Administration | Office | 86 | 48 | $97.25 | $8,363 |
| 95983 Electrical Nerve Conductivity | Office | 82 | 36 | $36.18 | $2,967 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 66 | 33 | $0.50 | $33.31 |
| 99205 Office E&M - New | Office | 63 | 63 | $152.45 | $9,604 |
| 99204 Office E&M - New | Office | 59 | 59 | $114.01 | $6,727 |
| 95984 Electrical Nerve Conductivity | Office | 53 | 23 | $31.36 | $1,662 |
| 99203 Office E&M - New | Office | 15 | 15 | $73.83 | $1,107 |
By year: 2022 $231K for 14,680 services; 2023 $158K for 10,971 services; 2024 $395K for 64,045 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carmen R Fuentes prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 610 prescriptions and refills. In total Carmen R Fuentes wrote 3,119 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 610 | 1,584 | 207 | $27K |
| Propranolol Hcl Generic | 187 | 454 | 71 | $5,528 |
| Primidone Generic | 185 | 489 | 61 | $3,651 |
| Donepezil Hcl Generic | 181 | 483 | 65 | $2,132 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 165 | 390 | 56 | $20K |
| Gabapentin Generic | 117 | 247 | 46 | $2,256 |
| Amantadine Amantadine Hcl | 112 | 276 | 43 | $7,291 |
| Memantine Hcl Generic | 87 | 182 | 23 | $2,290 |
| Carbidopa-Levodopa-Entacapone Carbidopa/Levodopa/Entacapone | 85 | 205 | 23 | $34K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 80 | 204 | 25 | $1,282 |
| Austedo Deutetrabenazine | 80 | 80 | Under 11 | $830K |
| Entacapone Generic | 71 | 174 | 24 | $14K |
| Topiramate Generic | 64 | 139 | 16 | $645 |
| Rytary Carbidopa/Levodopa | 61 | 137 | 14 | $83K |
| Austedo Xr Deutetrabenazine | 59 | 59 | Under 11 | $551K |
Brand drugs: - claims; generic drugs: 2,664 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carmen R Fuentes $95K ($95K in general payments such as food, travel and fees) from 13 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $46K.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 35 | $46K |
| Neurocrine BioSciences, Inc. NBIX | 58 | $45K |
| Amneal Pharmaceuticals LLC AMRX | 8 | $2,278 |
| Medtronic, Inc. MDT | 15 | $1,729 |
| Abbvie Inc. ABBV | 3 | $60.26 |
| TG Therapeutics, Inc. TGTX | 1 | $42.32 |
| Genentech USA, Inc. ROG.SW | 1 | $34.38 |
| Pfizer Inc. PFE | 1 | $33.16 |
| Averitas Pharma Inc. | 1 | $28.27 |
| Janssen Biotech, Inc. JNJ | 1 | $26.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.